Free Trial
→ REVEALED: Something Big Happening Behind White House Doors (From Paradigm Press) (Ad)tc pixel Free VRCA Stock Alerts

Verrica Pharmaceuticals (VRCA) SEC Filings & 10K Form

Verrica Pharmaceuticals logo
$4.75 -0.19 (-3.85%)
Closing price 09/12/2025 04:00 PM Eastern
Extended Trading
$4.69 -0.06 (-1.26%)
As of 09/12/2025 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Verrica Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
08/14/2025
8:41 PM		ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
08/12/2025
3:20 PM		Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/23/2025
7:00 AM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/01/2025
7:02 AM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/09/2025
3:45 PM		PRYGOCKI MARK A SR (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM		Eichenfield Lawrence (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM		Nguyen Diem (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:45 PM		Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:57 PM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
2:20 PM		ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/13/2025
3:36 PM		Verrica Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2025
3:19 PM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
5:06 AM		Verrica Pharmaceuticals (Filer)
Form DEFR14A
04/22/2025
6:15 AM		Verrica Pharmaceuticals (Filer)
Form DEF 14A
04/22/2025
6:18 AM		Verrica Pharmaceuticals (Filer)
Form DEFA14A
04/22/2025
6:20 AM		Verrica Pharmaceuticals (Filer)
Form ARS
04/02/2025
3:31 PM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2025
3:31 PM		Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2025
3:32 PM		Corcoran Gavin (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2025
6:08 AM		Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/26/2025
6:10 AM		Rosenberg Noah L. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2025
11:15 PM		Verrica Pharmaceuticals (Filer)
Form EFFECT
03/18/2025
5:45 PM		Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
5:45 PM		Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
4:05 PM		Verrica Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/11/2025
3:23 PM		Verrica Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
4:01 PM		ARMISTICE CAPITAL, LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/09/2024
5:22 PM		PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
12/09/2024
4:17 PM		Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/09/2024
4:18 PM		Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
3:55 PM		Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/21/2024
3:53 PM		Verrica Pharmaceuticals (Filer)
Form 424B5
11/20/2024
4:06 PM		Verrica Pharmaceuticals (Filer)
Form 424B5
11/20/2024
4:08 PM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:32 AM		Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2024
7:59 PM		Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
8:02 PM		Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
8:03 PM		Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/06/2024
8:04 PM		Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:11 PM		Verrica Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/04/2024
3:17 PM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:15 PM		Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/08/2024
3:16 PM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2024
3:37 PM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2024
3:15 PM		Verrica Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/23/2024
3:15 PM		Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VRCA) was last updated on 9/13/2025 by MarketBeat.com Staff
From Our Partners
Why Trump’s “Smart Dollar” could rewrite the rules
MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...
Stansberry Research | Sponsoredtc pixel
Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...
Brownstone Research | Sponsoredtc pixel
Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...
Banyan Hill Publishing | Sponsoredtc pixel
Retire Comfortably with These New Monthly Income ETFs?
Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...
Investors Alley | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...
Paradigm Press | Sponsoredtc pixel
“Sell Nvidia before earnings”
Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...
InvestorPlace | Sponsoredtc pixel